MSD has signed an agreement with Variational AI to use its generative AI (genAI) platform Enki in the discovery of new small-molecule medicines. Vancouver, Canada-based Variational – which emerged in ...
With reported 3x speed gains and limited degradation in output quality, the method targets one of the biggest pain points in production AI systems: latency at scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results